Selected research
Industry Research
Esomeprazole Capsule Industry Research Report 2026
Market perspective
The global Esomeprazole Capsule market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Esomeprazole Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Esomeprazole Capsule is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Esomeprazole Capsule is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Esomeprazole Capsule include Teva., Sandoz, Sanofi, Novartis, Mylan, Stada, Saval Pharmaceutical, Mepha and KernPharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Esomeprazole Capsule market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Esomeprazole Capsule Market by Company
Teva.
Sandoz
Sanofi
Novartis
Mylan
Stada
Saval Pharmaceutical
Mepha
KernPharm
Garmish Pharmaceuticals
CQ Lummy
Blaskov
AstraZeneca AB
Actavis
Esomeprazole Capsule Segment by Type
Short-Term Use
Long-Term Use
Esomeprazole Capsule Segment by Application
Duodenal Ulcers
Gastroesophageal Reflux Disease
Others
Esomeprazole Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esomeprazole Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Esomeprazole Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esomeprazole Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Esomeprazole Capsule manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Esomeprazole Capsule by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Esomeprazole Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Short-Term Use
- Long-Term Use
Applications
- Duodenal Ulcers
- Gastroesophageal Reflux Disease
- Others
Companies covered
- Teva.
- Sandoz
- Sanofi
- Novartis
- Mylan
- Stada
- Saval Pharmaceutical
- Mepha
- KernPharm
- Garmish Pharmaceuticals
- CQ Lummy
- Blaskov
- AstraZeneca AB
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Esomeprazole Capsule Market Size (2021-2032)
- 2.2.2 Global Esomeprazole Capsule Sales (2021-2032)
- 2.2.3 Global Esomeprazole Capsule Market Average Price (2021-2032)
- 2.3 Esomeprazole Capsule by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Short-Term Use
- 2.3.3 Long-Term Use
- 2.4 Esomeprazole Capsule by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Duodenal Ulcers
- 2.4.3 Gastroesophageal Reflux Disease
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Esomeprazole Capsule Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Esomeprazole Capsule Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Esomeprazole Capsule Revenue of Manufacturers (2021-2026)
- 3.4 Global Esomeprazole Capsule Average Price by Manufacturers (2021-2026)
- 3.5 Global Esomeprazole Capsule Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Esomeprazole Capsule, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Esomeprazole Capsule, Product Type & Application
- 3.8 Global Manufacturers of Esomeprazole Capsule, Established Date
- 3.9 Global Esomeprazole Capsule Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva.
- 4.1.1 Teva. Company Information
- 4.1.2 Teva. Business Overview
- 4.1.3 Teva. Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva. Esomeprazole Capsule Product Portfolio
- 4.1.5 Teva. Recent Developments
- 4.2 Sandoz
- 4.2.1 Sandoz Company Information
- 4.2.2 Sandoz Business Overview
- 4.2.3 Sandoz Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sandoz Esomeprazole Capsule Product Portfolio
- 4.2.5 Sandoz Recent Developments
- 4.3 Sanofi
- 4.3.1 Sanofi Company Information
- 4.3.2 Sanofi Business Overview
- 4.3.3 Sanofi Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sanofi Esomeprazole Capsule Product Portfolio
- 4.3.5 Sanofi Recent Developments
- 4.4 Novartis
- 4.4.1 Novartis Company Information
- 4.4.2 Novartis Business Overview
- 4.4.3 Novartis Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Novartis Esomeprazole Capsule Product Portfolio
- 4.4.5 Novartis Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Esomeprazole Capsule Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Stada
- 4.6.1 Stada Company Information
- 4.6.2 Stada Business Overview
- 4.6.3 Stada Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Stada Esomeprazole Capsule Product Portfolio
- 4.6.5 Stada Recent Developments
- 4.7 Saval Pharmaceutical
- 4.7.1 Saval Pharmaceutical Company Information
- 4.7.2 Saval Pharmaceutical Business Overview
- 4.7.3 Saval Pharmaceutical Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Saval Pharmaceutical Esomeprazole Capsule Product Portfolio
- 4.7.5 Saval Pharmaceutical Recent Developments
- 4.8 Mepha
- 4.8.1 Mepha Company Information
- 4.8.2 Mepha Business Overview
- 4.8.3 Mepha Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mepha Esomeprazole Capsule Product Portfolio
- 4.8.5 Mepha Recent Developments
- 4.9 KernPharm
- 4.9.1 KernPharm Company Information
- 4.9.2 KernPharm Business Overview
- 4.9.3 KernPharm Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 KernPharm Esomeprazole Capsule Product Portfolio
- 4.9.5 KernPharm Recent Developments
- 4.10 Garmish Pharmaceuticals
- 4.10.1 Garmish Pharmaceuticals Company Information
- 4.10.2 Garmish Pharmaceuticals Business Overview
- 4.10.3 Garmish Pharmaceuticals Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Garmish Pharmaceuticals Esomeprazole Capsule Product Portfolio
- 4.10.5 Garmish Pharmaceuticals Recent Developments
- 4.11 CQ Lummy
- 4.11.1 CQ Lummy Company Information
- 4.11.2 CQ Lummy Business Overview
- 4.11.3 CQ Lummy Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CQ Lummy Esomeprazole Capsule Product Portfolio
- 4.11.5 CQ Lummy Recent Developments
- 4.12 Blaskov
- 4.12.1 Blaskov Company Information
- 4.12.2 Blaskov Business Overview
- 4.12.3 Blaskov Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Blaskov Esomeprazole Capsule Product Portfolio
- 4.12.5 Blaskov Recent Developments
- 4.13 AstraZeneca AB
- 4.13.1 AstraZeneca AB Company Information
- 4.13.2 AstraZeneca AB Business Overview
- 4.13.3 AstraZeneca AB Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AstraZeneca AB Esomeprazole Capsule Product Portfolio
- 4.13.5 AstraZeneca AB Recent Developments
- 4.14 Actavis
- 4.14.1 Actavis Company Information
- 4.14.2 Actavis Business Overview
- 4.14.3 Actavis Esomeprazole Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Actavis Esomeprazole Capsule Product Portfolio
- 4.14.5 Actavis Recent Developments
5 Global Esomeprazole Capsule Market Scenario by Region
- 5.1 Global Esomeprazole Capsule Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Esomeprazole Capsule Sales by Region: 2021-2032
- 5.2.1 Global Esomeprazole Capsule Sales by Region: 2021-2026
- 5.2.2 Global Esomeprazole Capsule Sales by Region: 2027-2032
- 5.3 Global Esomeprazole Capsule Revenue by Region: 2021-2032
- 5.3.1 Global Esomeprazole Capsule Revenue by Region: 2021-2026
- 5.3.2 Global Esomeprazole Capsule Revenue by Region: 2027-2032
- 5.4 North America Esomeprazole Capsule Market Facts & Figures by Country
- 5.4.1 North America Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Esomeprazole Capsule Sales by Country (2021-2032)
- 5.4.3 North America Esomeprazole Capsule Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Esomeprazole Capsule Market Facts & Figures by Country
- 5.5.1 Europe Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Esomeprazole Capsule Sales by Country (2021-2032)
- 5.5.3 Europe Esomeprazole Capsule Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Esomeprazole Capsule Market Facts & Figures by Country
- 5.6.1 Asia Pacific Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Esomeprazole Capsule Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Esomeprazole Capsule Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Esomeprazole Capsule Market Facts & Figures by Country
- 5.7.1 South America Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Esomeprazole Capsule Sales by Country (2021-2032)
- 5.7.3 South America Esomeprazole Capsule Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Esomeprazole Capsule Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Esomeprazole Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Esomeprazole Capsule Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Esomeprazole Capsule Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Esomeprazole Capsule Sales by Type (2021-2032)
- 6.1.1 Global Esomeprazole Capsule Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Esomeprazole Capsule Sales Market Share by Type (2021-2032)
- 6.2 Global Esomeprazole Capsule Revenue by Type (2021-2032)
- 6.2.1 Global Esomeprazole Capsule Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Esomeprazole Capsule Revenue Market Share by Type (2021-2032)
- 6.3 Global Esomeprazole Capsule Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Esomeprazole Capsule Sales by Application (2021-2032)
- 7.1.1 Global Esomeprazole Capsule Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Esomeprazole Capsule Sales Market Share by Application (2021-2032)
- 7.2 Global Esomeprazole Capsule Revenue by Application (2021-2032)
- 7.2.1 Global Esomeprazole Capsule Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Esomeprazole Capsule Revenue Market Share by Application (2021-2032)
- 7.3 Global Esomeprazole Capsule Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Esomeprazole Capsule Value Chain Analysis
- 8.1.1 Esomeprazole Capsule Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Esomeprazole Capsule Production Mode & Process
- 8.2 Esomeprazole Capsule Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Esomeprazole Capsule Distributors
- 8.2.3 Esomeprazole Capsule Customers
9 Global Esomeprazole Capsule Analyzing Market Dynamics
- 9.1 Esomeprazole Capsule Industry Trends
- 9.2 Esomeprazole Capsule Industry Drivers
- 9.3 Esomeprazole Capsule Industry Opportunities and Challenges
- 9.4 Esomeprazole Capsule Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst